CymaBay Therapeutics, a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases, has announced that Paul  Quinlan joined the company as general counsel and corporate secretary. As CymaBay’s chief legal officer he will be responsible for all legal affairs, including providing legal advice to CymaBay’s board of directors and senior management. Mr Quinlan comes to CymaBay from Terravia Holdings (formerly Solazyme), where since 2010 he has served as general counsel and secretary, overseeing the legal function.  Prior to that, Mr Quinlan was general counsel and secretary for Metabolex and chief corporate securities counsel for Maxygen.  He was also an associate at Cravath, Swaine, & Moore and Cooley where he worked with biopharma and medical device companies.

Quality Systems, known as NextGen Healthcare, has appointed Jeffrey Linton as general counsel. Mr Linton will oversee all legal-related matters of NextGen Healthcare. He assumes the role from Jocelyn Leavitt, who has been serving as general counsel since June 2013. Mr Linton will report to CEO Rusty Frantz and will lead the company’s legal affairs, regulatory and compliance groups. Most recently, he served as general counsel and corporate secretary of Applied Proteomics, a company that develops noninvasive, blood-based tests for monitoring and early detection of disease. Previously, he served as general counsel and company secretary of Sequenom and was GC at biomedical testing company Beckman Coulter, a biomedical testing products company. He also held roles at Serologicals Corporation.